1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow resminostat: new trials by email Literature Review of resminostat trials Research Report on resminostat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) Resminostat, Sorafenib - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | Yakult Honsha Co., LTD | 179 | 2013-04-01 | 2018-01-16 |
Japan (1) · South Korea (1)